Characteristics | N (%) | P value | ||
---|---|---|---|---|
 | Total | Male | Female |  |
Age at surgery(year) | Â | Â | Â | 0.391 |
≤ 52 | 101(54.0) | 43(42.6) | 58(57.4) |  |
>52 | 86(46.0) | 42(48.8) | 44(51.2) | Â |
Heredity | Â | Â | Â | 0.122 |
Hereditary | 33(17.6) | 18(54.5) | 15(45.5) | Â |
sporadic | 154(82.4) | 92(59.7) | 62(40.3) | Â |
Multifocal | Â | Â | Â | 0.334 |
Yes | 55(29.4) | 28(50.9) | 27(49.1) | Â |
No | 132(70.6) | 57(43.2) | 75(56.8) | Â |
ETE | Â | Â | Â | 0.302 |
Yes | 76(40.6) | 38(50.0) | 38(50.0) | Â |
No | 111(59.4) | 47(42.3) | 64(57.7) | Â |
Bilateral lesions | Â | Â | Â | 0.666 |
Yes | 20(10.7) | 10(50.0%) | 10(50.0%) | Â |
No | 167(89.3) | 75(44.9) | 92(55.1) | Â |
Tumor size(cm) | Â | Â | Â | 0.572 |
≤ 2 | 120(64.2) | 55(45.8) | 65(54.2) |  |
2–4 | 57(30.5) | 24(42.1) | 33(57.9) |  |
>4 | 10(5.3) | 6(60.0) | 4(40.0) | Â |
pT stage | Â | Â | Â | 0.358 |
T1/T2 | 108(57.7) | 46(42.6) | 62(57.4) | Â |
T3/T4 | 79(42.3) | 39(49.4) | 40(50.6) | Â |
pN stage | Â | Â | Â | <0.001 * |
N0 | 87(46.5) | 28(32.2) | 59(67.8) | Â |
N1a | 26(13.9) | 12(46.2) | 14(53.8) | Â |
N1b | 74(39.6) | 45(60.8) | 29(39.2) | Â |
8th TNM stage | Â | Â | Â | <0.001 * |
I/II | 77(41.1) | 21(27.3) | 56(72.7) | Â |
III/IV | 110(58.9) | 64(58.2) | 46(41.8) | Â |
Coexist HT | Â | Â | Â | 0.086 |
Yes | 24(12.8) | 7(29.2) | 17(70.8) | Â |
No | 163(87.2) | 78(47.9) | 85(52.1) | Â |
Pathology | Â | Â | Â | 0.290 |
Only MTC | 105(56.1) | 53(50.5) | 52(49.5) | Â |
With adenomatous goiter | 9(4.8) | 5(55.6) | 4(44.4) | Â |
With nodular goiter | 51(27.3) | 18(35.3) | 33(64.7) | Â |
With PTC | 22(11.8) | 9(40.9) | 13(59.1) | Â |
Recurrence | Â | Â | Â | 0.649 |
Yes | 22(11.8) | 11(50.0) | 11(50.0) | Â |
No | 165(88.2) | 74(44.8) | 91(55.2) | Â |
Biochemical cure | Â | Â | Â | 0.649 |
Yes | 98(52.4) | 43(43.9) | 55(56.1) | Â |
No | 89(47.6) | 42(47.2) | 47(52.8) | Â |
IDO2 expression | Â | Â | Â | 0.017 * |
High | 77(41.1) | 43(55.8) | 34(44.2) | Â |
Low | 110(58.9) | 42(38.2) | 68(61.8) | Â |